Tower Research Capital (TRC)’s Outset Medical OM Stock Holding History
Bought
Maintained
Sold
Other funds holding OM
BCM
Tower Research Capital (TRC)'s OM Position: Q3 2026 in Review
Tower Research Capital (TRC) reduced its Outset Medical (OM) stake by 59% in Q3 2026, selling an estimated $11.3K and leaving 1,893 shares worth $5.68K. The position accounts for ﹤0.01% of the portfolio, ranked #4592.
Tower Research Capital (TRC) first reported a position in OM in Q3 2020 and has held it in 24 quarters since. The position peaked at $184K in Q3 2023. 77 funds tracked by Wall St. Rank hold OM as of Q3 2026.
- Tower Research Capital (TRC) held 1,893 shares of Outset Medical worth $5.68K as of Q3 2026.
- Tower Research Capital (TRC) sold 2,775 Outset Medical shares in Q3 2026, an estimated $11.3K.
- Outset Medical made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #4592 holding.
- Tower Research Capital (TRC) first reported a position in Outset Medical in Q3 2020 and has held it in 24 quarters since.
- Tower Research Capital (TRC)'s Outset Medical position peaked at $184K in Q3 2023.
- 77 funds tracked by Wall St. Rank held Outset Medical as of Q3 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.